Shingal Majuru

Title: Shingal Majuru: Innovator in Oral Insulin Therapies

Introduction

Shingal Majuru is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of diabetes treatment through his innovative approaches to insulin therapy. His work focuses on improving the quality of life for individuals with impaired glucose tolerance and diabetes.

Latest Patents

Shingal Majuru holds a patent for "Oral insulin therapies and protocol." This patent outlines methods for treating impaired glucose tolerance and both early and late-stage diabetes in mammals. The invention aims to prophylactically spare β-cell function, aid in preventing β-cell death, and prevent the onset of overt diabetes in mammals with type 2 diabetes. The methods involve orally administering insulin and a delivery agent that facilitates insulin absorption from the gastrointestinal tract shortly before mealtime. This approach achieves improved glycemic control without the risks commonly associated with insulin therapy, such as hypoglycemia and weight gain.

Career Highlights

Majuru is currently associated with Emisphere Technologies, Inc., where he continues to develop and refine his innovative therapies. His work has the potential to revolutionize diabetes management and improve patient outcomes significantly.

Collaborations

Shingal Majuru has collaborated with notable professionals in the field, including Ehud Arbit and Michael M. Goldberg. These collaborations have further enhanced the development and application of his patented methods.

Conclusion

Shingal Majuru's contributions to oral insulin therapies represent a significant advancement in diabetes treatment. His innovative methods promise to improve glycemic control and enhance the quality of life for many individuals living with diabetes.